The effect of a training program of non-alcoholic fatty liver

The effect of a training program on biochemical markers of non-alcoholic fatty liver

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20190309042987N1

Enrollment

Registered

2019-04-19

Start date

2018-12-22

Completion date

Unknown

Last updated

2019-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

non-alcholic fatty liver desease. Fatty (change of) liver, not elsewhere classified

Interventions

Intervention 1: Supplementary group group: 500 Gram pillow after breakfast and dinner for 3 months. Intervention 2: Placebo group: Two daily pills containing wheat flour for 3 months. Intervention 3:

Eligibility

Sex/Gender

Female

Age

40 Years to 60 Years

Inclusion criteria

Inclusion criteria: Women 40-60 years old Having a non-alcoholic fatty liver with varying degrees Not having any illness other than fatty liver Being a menopause

Exclusion criteria

Exclusion criteria: Having heart-respiratory disease, kidney, hypertension Acute diseases such as viral hepatitis and other non-alcoholic liver diseases other than non-alcoholic fatty liver (such as viral hepatitis B, C, autoimmune hepatitis, celiac disease, Wilson, a 1-antithyrium deficiency and hemochromatosis) Alcohol and tobacco use Having regular exercise in the last 6 months, Coagulation disorders, Impairment of the immune system, Pulmonary problems, hypothyroidism Damage to the limb that prevents exercise. Having any surgery, Slight and waning weight loss Chronic or acute liver disorders, cancer, liver transplantation, Pregnancy, breastfeeding, Use of any supplement and medicinal herbs

Design outcomes

Primary

Measure	Time frame
Cholesterol. Timepoint: Start and end of study. Method of measurement: Radiocommunication.;LDL. Timepoint: Start and end of study. Method of measurement: Radiocommunication.;HDL. Timepoint: Start and end of study. Method of measurement: Radiocommunication.;AST. Timepoint: Start and end of study. Method of measurement: Enzymatic method using kit.;ALT. Timepoint: Start and end of study. Method of measurement: Enzymatic method using kit.;ALP. Timepoint: Start and end of study. Method of measurement: Enzymatic method using kit.;Degree of fatty liver. Timepoint: Start and end of study. Method of measurement: Sonography.	—

Measure

Time frame

Cholesterol. Timepoint: Start and end of study. Method of measurement: Radiocommunication.;LDL. Timepoint: Start and end of study. Method of measurement: Radiocommunication.;HDL. Timepoint: Start and end of study. Method of measurement: Radiocommunication.;AST. Timepoint: Start and end of study. Method of measurement: Enzymatic method using kit.;ALT. Timepoint: Start and end of study. Method of measurement: Enzymatic method using kit.;ALP. Timepoint: Start and end of study. Method of measurement: Enzymatic method using kit.;Degree of fatty liver. Timepoint: Start and end of study. Method of measurement: Sonography.

—

Secondary

Measure	Time frame
Body mass index. Timepoint: Start and end of study. Method of measurement: Using scales and centimeters.;Waist to hip ratio. Timepoint: Start and end of study. Method of measurement: Using centimeters.;Body fat percentage. Timepoint: Start and end of study. Method of measurement: Caliper.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNarges Aliniya

Islamic Azad University

Aliniya.n@yahoo.com+98 13 4483 6878

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026